Huss has the potential to have an immediate positive impact on patient care
FAQs What happens if GLP-1 therapy is stopped suddenly
Pulmonary Aspiration Warning for GLP-1 (Glucagon-like peptide-1) Diabetes and Weight Loss Meds GLP-1 medications help patients lose weight by delaying the movement of food from the stomach into the small intestine, suppressing appetite
This synergistic effect may optimize the intracellular concentration of L-carnitine, thereby augmenting its fat-burning potential
Breastfeeding parents typically need: About 2,000 calories per day for baseline metabolism An additional ~250 calories or more for milk production If appetite suppression leads to inadequate calorie intake, this can result in: Reduced milk supply Dehydration Fatigue or dizziness Nutrient deficiencies Potential changes in breast milk nutrient composition In other words, the primary concern during breastfeeding is maintaining adequate nutrition not medication exposure in milk
Nausea is the single most common side effect of GLP-1 receptor agonist medications and the most common reason patients in clinical trials and in clinic discontinue treatment